These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10422886)

  • 1. Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist.
    Sakurada C; Watanabe C; Inoue M; Tan-No K; Ando R; Kisara K; Sakurada T
    Peptides; 1999; 20(2):301-4. PubMed ID: 10422886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
    Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
    Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
    Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
    Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
    Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
    Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
    Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
    Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.
    Darmani NA; Wang Y; Abad J; Ray AP; Thrush GR; Ramirez J
    Brain Res; 2008 Jun; 1214():58-72. PubMed ID: 18471804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature and agonist dependency of tachykinin NK1 receptor antagonist potencies in rat isolated superior cervical ganglion.
    Hawcock AB; Beresford IJ; Marshall FH; Hagan RM
    Eur J Pharmacol; 1995 Dec; 294(1):163-71. PubMed ID: 8788428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
    Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
    Picard P; Boucher S; Regoli D; Gitter BD; Howbert JJ; Couture R
    Eur J Pharmacol; 1993 Mar; 232(2-3):255-61. PubMed ID: 7682180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider.
    Palframan RT; Costa SK; Wilsoncroft P; Antunes E; de Nucci G; Brain SD
    Br J Pharmacol; 1996 May; 118(2):295-8. PubMed ID: 8735630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
    Bristow LJ; Young L
    Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord].
    Sun XC; Li WB; Li SQ; Li QJ; Chen XL; Ai J
    Sheng Li Xue Bao; 2003 Dec; 55(6):677-83. PubMed ID: 14695485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
    Hall JM; Mitchell D; Morton IK
    Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of evidence for tachykinin NK1 receptor-mediated neutrophil accumulation in the rat cutaneous microvasculature by thermal injury.
    Pintér E; Brown B; Hoult JR; Brain SD
    Eur J Pharmacol; 1999 Mar; 369(1):91-8. PubMed ID: 10204686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Ca(2+)-sensitive K+ currents in NG 108-15 cells by substance P and related tachykinins.
    Phenna S; Carpenter E; Peers C; Maudsley S; Gent JP
    Br J Pharmacol; 1996 Sep; 119(2):315-20. PubMed ID: 8886415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY303870, a centrally active neurokinin-1 antagonist with a long duration of action.
    Iyengar S; Hipskind PA; Gehlert DR; Schober D; Lobb KL; Nixon JA; Helton DR; Kallman MJ; Boucher S; Couture R; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):774-85. PubMed ID: 9023291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.